Long-term effects of cyproterone acetate on the pituitary adrenal axis in adult women.
Function of the pituitary-adrenal axis was assessed in 16 adult female patients who had been taking cyproterone acetate for greater than 1 year. Some evidence of reduced basal cortisol output was seen in 25% of the patients, but plasma cortisol levels could be stimulated both by hypoglycaemia and by direct corticotrophin (ACTH) stimulation. The latter effect was confirmed by analysis of steroid excretion in urine although basal excreation rates indicated extensive adrenal suppression. These results suggest that cyproterone acetate does have some glucocorticoid activity which is able partially to suppress the pituitary--adrenal axis, but leaves it still responsive to stress.
D000328:Adult; D000505:Alopecia / Q000188:drug therapy; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D005260:Female; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000503:physiopathology
D017373:Cyproterone Acetate; D003534:Cyproterone; D006854:Hydrocortisone